IVZ
69
3
PVH
34
2
WEC
55
2
COF
65
8
SE
80
26
NTAP
55
3
RCL
62
7
PYPL
33
2
DE
45
2
VMC
80
5
CMG
35
6
BWA
55
2
FFIV
58
3
MOS
39
-4
AKAM
37
2
GT
23
3
MCO
61
5
AMAT
49
3
NSC
62
2
DUK
55
-2
IVZ
69
3
PVH
34
2
WEC
55
2
COF
65
8
SE
80
26
NTAP
55
3
RCL
62
7
PYPL
33
2
DE
45
2
VMC
80
5
CMG
35
6
BWA
55
2
FFIV
58
3
MOS
39
-4
AKAM
37
2
GT
23
3
MCO
61
5
AMAT
49
3
NSC
62
2
DUK
55
-2
Financhill
Back

Bumble- Ordinary Shares - Class A Vs. Kymera Therapeutics Industry Stock Comparison

Buy
53

BMBL
Bumble- Ordinary Shares - Class A

Last Price:
$7.15
Seasonality Move:
-15.96%
Sell
33

KYMR
Kymera Therapeutics

Last Price:
$40.74
Seasonality Move:
-2.33%
Buy
53
Bumble- Ordinary Shares - Class A (BMBL) is a Buy

Is Bumble- Ordinary Shares - Class A a Buy, Sell or Hold?

  • The current Bumble- Ordinary Shares - Class A [BMBL] share price is $7.15. The Score for BMBL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • BMBL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $39.87. The Score for KYMR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMBL Stock Price Chart

What is Bumble- Ordinary Shares - Class A's stock price today?

  • The Bumble- Ordinary Shares - Class A share price today is $7.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMBL is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $39.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMBL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 51.94 Buy
Chaikin Money Flow: 1858528 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.62 - 7.92) Sell
Bollinger Bands (100): (4.43 - 6.89) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.79 Buy
Relative Strength Index (14 RSI): 37.76 Sell
Chaikin Money Flow: 839243 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.68 - 46.1) Sell
Bollinger Bands (100): (28.65 - 45.39) Buy

BMBL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.96 Buy
20-day SMA: 7.42 Sell
50-day SMA: 6.51 Buy
200-day SMA: 6.54 Buy
8-day EMA: 6.93 Buy
20-day EMA: 7.09 Buy
50-day EMA: 6.68 Buy
200-day EMA: 6.78 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.25 Sell
20-day SMA: 43.63 Sell
50-day SMA: 44.84 Sell
200-day SMA: 39.18 Buy
8-day EMA: 38.09 Buy
20-day EMA: 27.63 Buy
50-day EMA: 14.86 Buy
200-day EMA: 4.36 Buy

Bumble- Ordinary Shares - Class A Earnings Growth & BMBL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.57 per share, and a decrease next year of $1.09 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.30 per share, a decrease this year of $0.57 per share, and a decrease next year of $0.71 per share.

Bumble- Ordinary Shares - Class A Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):